Bill
S 772
Expands coverage for inpatient SUD care to 30 days without preauthorization across GIC, Medicaid, and private plans, with clinician‑determined medical necessity to improve access.
Purpose and intent
- The bill expands mandated coverage for substance use disorder (SUD) treatment in Massachusetts, requiring public and certain private plans to cover a continuum of inpatient and residential addiction services without prior authorization and to limit insurer utilization-review restrictions during an initial treatment period. The goal is to strengthen access to medically necessary addiction care and support smoother transitions from higher- to lower-intensity services.
Key provisions and changes
- New/clarified definitions (chapter 32A §17N and chapter 118E §10O):
- “Acute treatment services”: 24-hour medically supervised inpatient care (evaluation, withdrawal management, counseling, discharge planning).
- “Clinical stabilization services”: 24-hour clinically managed, post-detox treatment to begin recovery engagement.
- “Transitional support services”: short-term residential support, typically after clinical stabilization, to help transition to outpatient or other step-down care.
- Group Insurance Commission (GIC) coverage (chapter 32A):
- GIC must provide medically necessary acute, clinical stabilization, and transitional support services to active and retired Commonwealth employees insured through GIC for up to 30 days without requiring prior authorization.
- Admitting facilities must notify the insurer/carrier of admission and the initial treatment plan within 48 hours and later provide a projected discharge plan.
- Carriers may begin utilization review on day 14 but may not impose restrictions or deny further medically necessary acute/clinical/transitional services unless the patient has already received at least 30 consecutive days of those services.
- Substance use disorder evaluations ordered under M.G.L. c.111, §51½ must be covered without prior authorization.
- Medical necessity is to be determined by the treating clinician in consultation with the patient and documented in the medical record.
- Medicaid and commercial plan coverage (chapter 118E §10O):
- The Division of Medical Assistance and its contracted health insurers/plans, HMOs, behavioral health contractors and third‑party administrators must cover medically necessary acute treatment, clinical stabilization, and transitional support services (up to 30 days for stabilization/transitional services) without preauthorization.
- Same notification, utilization-review timing (may initiate review on day 14 but cannot deny/restrict before 30 consecutive days), and coverage for §51½ evaluations as above.
- Repeal: Section 10H of chapter 118E (added by ch. 258 of the Acts of 2014) is repealed (text does not specify content of 10H).
Who is affected
- Primary beneficiaries: adults and adolescents experiencing substance use disorder needing inpatient, stabilization, or short-term residential transitional support.
- Insured populations: GIC-insured active and retired state employees; Medicaid enrollees; members of private/commercial health plans, HMOs, and plans contracting with the Division of Medical Assistance.
- Providers/facilities offering acute, clinical stabilization, and transitional support services (new notification and documentation requirements).
- Insurers, health plans, behavioral health management firms, and utilization-review entities (limits on preauthorization and early denial).
Procedural status and timeline
- Introduced in the Senate (Senate No. 772) and presented by Senator John F. Keenan with multiple co-petitioners.
- Legislative actions (selected): read twice and referred to the Committee on Finance/Financial Services (2/27/2025); recorded as “SUBSTITUTED BY A924” (2/05/2025) and listed as having related/companion bill(s) A924 and HR 1801. A committee hearing was scheduled for 09/09/2025 (including virtual option).
- Current status shown: SUBSTITUTED BY A924 — readers should consult the substitute (A924) text for the version moving forward.
Notes
- The bill emphasizes clinician-determined medical necessity (in consultation with the patient) and creates a presumptive window (first 30 days) during which access to higher-intensity SUD care cannot be curtailed via utilization review or preauthorization requirements. For final enacted language or fiscal impacts, consult the substitute A924 and committee reports.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
